Mersana Therapeutics Inc (MRSN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MRSN | AZN | AMGN | GILD | BMY |
| Company | Mersana Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 28.90 | 202.64 | 347.46 | 140.12 | 58.70 |
| High | 30.39 | 204.29 | 356.10 | 141.77 | 59.54 |
| Low | 28.78 | 201.97 | 346.42 | 139.96 | 58.54 |
| Latest | 29.08 | 205.34 | 355.96 | 141.87 | 59.17 |
| Change | +0.04 | +1.07 | +6.15 | +0.33 | -0.03 |
| % Change | +0.14% | +0.52% | +1.76% | +0.23% | -0.05% |
| Volume | 712,400 | 406,500 | 1,043,949 | 944,500 | 1,761,800 |
| 20-Day Average Volume | 115,345 | 1,850,530 | 2,630,455 | 5,867,567 | 13,221,697 |
| Previous Close | 29.04 | 204.27 | 349.81 | 141.54 | 59.20 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 28.69 | 193.11 | 352.63 | 140.08 | 59.03 |
| 20-Day Raw Stochastic | 56.77% | 86.73% | 45.99% | 51.22% | 43.29% |
| 20-Day Relative Strength | 79.43 | 58.91 | 48.39 | 50.35 | 49.81 |
| Weighted Alpha | -22.76 | +52.53 | +24.61 | +36.15 | +22.63 |
| Today's Opinion | 100% Buy | 88% Buy | 56% Buy | 56% Buy | 48% Buy |
| Previous Opinion | 100% Buy | 88% Buy | 40% Buy | 56% Buy | 64% Buy |
| Last Month's Opinion | 100% Buy | 80% Buy | 88% Buy | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.02% since 12/26/25 | +1.38% since 04/01/26 | +0.04% since 04/01/26 | +0.66% since 04/01/26 | -4.50% since 04/01/26 |
| Low | 28.11 on 12/30/25 | 196.95 on 04/07/26 | 335.06 on 04/07/26 | 137.15 on 04/07/26 | 57.65 on 04/07/26 |
| High | 30.39 on 01/05/26 | 206.73 on 04/08/26 | 355.67 on 04/09/26 | 141.71 on 04/09/26 | 60.58 on 04/02/26 |
| 1-Month | |||||
| %Chg | +4.70% since 12/05/25 | +4.39% since 03/09/26 | -6.24% since 03/09/26 | -3.68% since 03/09/26 | -2.77% since 03/09/26 |
| Low | 27.80 on 12/08/25 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 30.39 on 01/05/26 | 206.73 on 04/08/26 | 380.14 on 03/11/26 | 149.38 on 03/10/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | +251.21% since 10/03/25 | +7.50% since 01/09/26 | +8.38% since 01/09/26 | +16.62% since 01/09/26 | +5.53% since 01/09/26 |
| Low | 7.54 on 11/07/25 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 53.54 on 01/21/26 |
| High | 30.39 on 01/05/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +301.80% since 07/03/25 | +19.65% since 10/09/25 | +19.63% since 10/09/25 | +20.98% since 10/09/25 | +31.94% since 10/09/25 |
| Low | 5.21 on 08/13/25 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 30.39 on 01/05/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 145,165 | 316,803,968 | 188,571,376 | 175,682,560 | 120,870,712 |
| Shares Outstanding, K | 4,999 | 1,550,908 | 539,068 | 1,241,222 | 2,041,735 |
| Annual Sales | 40,500,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -69,190,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 11,010,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -7,550,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.44 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.51 on 11/14/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 03/02/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.92 | 15.56 | 17.03 | 9.38 |